References
- Fung MK, Eder AF, Spitalnik SL, Westhoff CM. Technical manual. 19th ed. Bethesda, MD: American Association of Blood Banks, 2017.
- Reid ME, Lomas-Francis C, Olsson ML. The blood group antigens factsbook. 3rd ed. San Diego, CA: Elsevier, 2012.
- International Society of Blood Transfusion. Table of blood group antigens v.8_180620. Available at www.isbtweb. org/fileadmin/user_upload/Red_Cell_Terminology_and_ Immunogenetics/Table_of_blood_group_antigens_within_ systems_v8_180620.pdf. Accessed August 2018.
- Klein HC, Anstee DJ. Mollison’s blood transfusion in clinical medicine. 11th edition. Malden, MA: Blackwell Publishing, 2005.
- Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375–87.
- Moulds JJ, Case J, Anderson TD, Cooper ES. The first example of allo-anti-c produced by a c-positive individual. In: Recent advances in haematology, immunology and blood transfusion: proceedings of the plenary sessions of the joint meeting of the 19th congress of the International Society of Haematology and the 17th Congress of the International Society of Blood Transfusion, Budapest, August 1982. Wiley, 1983.
- Ong J, Walker PS, Schmulbach E, et al. Alloanti-c in a c-positive, JAL-positive patient. Vox Sang 2008;96:240–3.
- Pham BN, Peyrard T, Juszczak G, et al. Alloanti-c (RH4) revealing that the (C)ces haplotype encodes a partial c antigen. Transfusion 2009;49:1320–4.
- Hipsky CH, Lomas-Francis C, Fuchisawa A, et al. RHCE*ceCF encodes partial c and partial e not CELO, an antigen antithetical to Crawford. Transfusion 2011;51:25–31.
- Peyrard T, Pham BN, Poupal S, et al. Alloanti-c/ce in a c+ ceAR/Ce patient suggests that the rare RHCE*ceAR allele (ceAR) encodes a partial c antigen. Transfusion 2009;49:2406–11.
- Hipsky CH, Lomas-Francis C, Fuchisawa A, Reid M. RHCE*ceAR encodes a partial c (RH4) antigen. Immunohematology 2010;26:57–9.
- Simon TL, McCullough J, Snyder EL, Solheim BG, Strauss RG. Rossi’s principles of transfusion medicine. 5th ed. West Sussex, UK: Blackwell Publishing, 2016.
- Westhoff CM, Silberstein LE, Wylie DE. Evidence supporting the requirement for two proline residues for expression of c. Transfusion 1997;37:1123–30.
- Wang D, Lane C, Quillen K. Prevalence of RhD variants, confirmed by molecular genotyping, in a multiethnic prenatal population. Am J Clin Pathol 2010;134:438–42.
- Mezokh N, Song Y, Moulds JM, et al. Reliable identification of diverse RHD and RHCE variants in African American donors by Beadchip analysis (abstract). Transfusion 2009;49:120A.
- Westhoff CM, Vege S, Horn T, et al. RHCE*ceMO is frequently in cis to RHD*DAU0 and encodes a hr(S)-, hr (B)-, RH:-61 phenotype in black persons: clinical significance. Transfusion 2013;53:2983–9.
- Noizat-Pirenne F, Lee K, Pennec PY, et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: Identification and transfusion safety. Blood 2002;100: 4223–31.
- Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.